RankAlpha logo
Back to Rankings

DMAC

DiaMedica TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Positive clinical readouts or a strategic partnership plus non-dilutive funding lead to rapid re-rating; upside driven by licensing/milestone value.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Clinical failure or need for heavy dilution compresses equity value materially; low liquidity amplifies downside.
Momentum
18
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.57 · Bull $1.08 · Bear $0.17Analysis 2025-12-13; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2025-12-13 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $15.59
Why
Momentum18 · Δ7d -8.9
Value41 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Value remains the lead driver in the composite, 7D delta -0.0.

Contradictions & invalidation

  • Clinical failure or need for heavy dilution compresses equity value materially; low liquidity amplifies downside.
  • Mixed signals. Wait for cleaner trend confirmation.

Catalyst clock

2026-03-31

Partnership or licensing deal

Lead driver: Value · See fundamentals
Momentum
18
9% active weight
Current posture
7d trendSoftening
Δ7d
-8.9
Δ21d
-38.0
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade

Composite grade F. Momentum 18.4 / Value 41.2 / Sentiment 0.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-12-13. Scenario method

B+
Bull case
33%
Probability
Target price
$1.08
Analysis reference price unavailable
Analysis 2025-12-13 · RankAlpha Sentiment AI
Most likely
B
Base case
33%
Probability
Target price
$0.57
Analysis reference price unavailable
Analysis 2025-12-13 · RankAlpha Sentiment AI
B-
Bear case
33%
Probability
Target price
$0.17
Analysis reference price unavailable
Analysis 2025-12-13 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$356.99M
Beta
1.10
Shares Out
53.93M
P/E (TTM) · Derived
-9.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-11.01
Rev YoY
-100.0%
EPS YoY
+5.0%
Gross Margin
+97.7%
Op Margin
-
Net Debt
-$59.65M
Current Ratio
6.72
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data